Development of inhibitors in hemophilia A: An illustrated review

This illustrated review focuses on the development of inhibitors in patients with congenital hemophilia, which is the most serious treatment‐related complication in these patients. Hemophilia A (HA) is an inherited X‐linked bleeding disorder affecting 1:5000‐10 000 newborn males worldwide. It result...

Descripción completa

Detalles Bibliográficos
Autores principales: Jardim, Letícia Lemos, Chaves, Daniel Gonçalves, Rezende, Suely Meireles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Illustrated Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354390/
https://www.ncbi.nlm.nih.gov/pubmed/32685884
http://dx.doi.org/10.1002/rth2.12335

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354390/
https://www.ncbi.nlm.nih.gov/pubmed/32685884
http://dx.doi.org/10.1002/rth2.12335

Ejemplares similares